Beckman Coulter Diagnostics Receives 2015 Scientists’ Choice Award for Best New Clinical Laboratory Product

Access Anti-Müllerian Hormone (AMH) Assay Voted Best New Clinical Product of 2014

BREA, Calif. — (August 31, 2015) — Beckman Coulter Diagnostics’ automated Access Anti-Müllerian Hormone (AMH) assay* was recently selected as the Best New Clinical Laboratory Product of 2014 for the 2015 Scientists’ Choice Award by members of SelectScience®. The award was presented this summer at this year’s American Association for Clinical Chemistry (AACC) Clinical Lab Expo in Atlanta, GA. 

The automated Access Anti-Müllerian Hormone (AMH) assay* is Beckman Coulter’s latest innovation in women’s health testing and further advances the company’s rich 15-year history and experience in supporting global fertility assessment and treatment.  

The Access AMH assay brings automation and convenience to Beckman Coulter’s established AMH tests, which include the AMH Gen II ELISA assay and the Immunotech EIA AMH/MIS assay. The company’s AMH assays have become the industry standard since the first commercial AMH assay was introduced in 1999, as evidenced by more than 2,000 scientific articles and publications.  

“Beckman Coulter is humbled and thrilled to receive the Scientists’ Choice Award from SelectScience,” said John Blackwood, senior vice president of Beckman Coulter’s Chemistry/Immunoassay business unit. “Beckman Coulter has been pioneering the AMH immunoassay space since 1999. Last year we launched the automated assay and we are honored that its value is being acknowledged by clinicians.” 

This year’s final nominees included Abbott, Alere, Randox, Roche and Siemens. Being among an elite group of competitors further demonstrates how Beckman Coulter offers solutions that continue to move healthcare forward. 

To view a video of the award presentation click here.

 About Beckman Coulter

Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Beckman Coulter's instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For 80 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes, offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, microbiology, automation and information systems. Beckman Coulter is dedicated to advancing healthcare for every person and moving science, innovation and the lab forward. For more information, visit

*phi, or the Prostate Health Index, is a combined set of blood tests, PSA, free PSA and p2PSA.

©2016 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.